158 related articles for article (PubMed ID: 35214599)
1. The Population-Wide Risk-Benefit Profile of Extending the Primary COVID-19 Vaccine Course Compared with an mRNA Booster Dose Program.
Shiri T; Evans M; Talarico CA; Morgan AR; Mussad M; Buck PO; McEwan P; Strain WD
Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214599
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851
[TBL] [Abstract][Full Text] [Related]
3. Hospitalisations and Deaths Averted by COVID-19 Vaccination in Navarre, Spain, 2021-2022.
Martínez-Baz I; Trobajo-Sanmartín C; Miqueleiz A; Egüés N; García Cenoz M; Casado I; Navascués A; Fernández-Huerta M; Echeverría A; Guevara M; Ezpeleta C; Castilla J
Vaccines (Basel); 2024 Jan; 12(1):. PubMed ID: 38250871
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups.
Kelly SL; Le Rutte EA; Richter M; Penny MA; Shattock AJ
Infect Dis Ther; 2022 Oct; 11(5):2045-2061. PubMed ID: 36094720
[TBL] [Abstract][Full Text] [Related]
5. Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study.
Massonnaud CR; Roux J; Colizza V; Crépey P
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335111
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
[TBL] [Abstract][Full Text] [Related]
7. Assessing COVID-19 Vaccine Uptake and Effectiveness Through the North West London Vaccination Program: Retrospective Cohort Study.
Glampson B; Brittain J; Kaura A; Mulla A; Mercuri L; Brett SJ; Aylin P; Sandall T; Goodman I; Redhead J; Saravanakumar K; Mayer EK
JMIR Public Health Surveill; 2021 Sep; 7(9):e30010. PubMed ID: 34265740
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of booster BCG vaccination in preventing Covid-19 infection.
Amirlak L; Haddad R; Hardy JD; Khaled NS; Chung MH; Amirlak B
Hum Vaccin Immunother; 2021 Nov; 17(11):3913-3915. PubMed ID: 34403297
[TBL] [Abstract][Full Text] [Related]
10. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
Milne GJ; Carrivick J; Whyatt D
BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India.
Sharma N; Basu S; Lalwani H; Rao S; Malik M; Garg S; Shrivastava R; Singh MM
Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514993
[TBL] [Abstract][Full Text] [Related]
12. Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study.
Yadete T; Batra K; Netski DM; Antonio S; Patros MJ; Bester JC
Vaccines (Basel); 2021 Dec; 9(12):. PubMed ID: 34960170
[TBL] [Abstract][Full Text] [Related]
13. The potential impact of an HIV vaccine with rapidly waning protection on the epidemic in Southern Africa: examining the RV144 trial results.
Andersson KM; Paltiel AD; Owens DK
Vaccine; 2011 Aug; 29(36):6107-12. PubMed ID: 21736912
[TBL] [Abstract][Full Text] [Related]
14. Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal.
Caetano C; Morgado ML; Patrício P; Leite A; Machado A; Torres A; Pereira JF; Namorado S; Sottomayor A; Peralta-Santos A; Nunes B
Vaccine; 2022 Nov; 40(49):7115-7121. PubMed ID: 36404429
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Impact of SARS-CoV-2 Variants on the COVID-19 Epidemic and Social Restoration in the United States: A Mathematical Modelling Study.
Li R; Li Y; Zou Z; Liu Y; Li X; Zhuang G; Shen M; Zhang L
Front Public Health; 2021; 9():801763. PubMed ID: 35083192
[No Abstract] [Full Text] [Related]
16. Adverse reactions and safety profile of the mRNA COVID-19 vaccines among Asian military personnel.
Tan JTC; Tan C; Teoh J; Wahab MT; Tan GZ; Chin RYZ; Lee A; Mutalib A; Lim PL
Ann Acad Med Singap; 2021 Nov; 50(11):827-837. PubMed ID: 34877586
[TBL] [Abstract][Full Text] [Related]
17. Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland.
Rzymski P; Poniedziałek B; Fal A
Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835217
[TBL] [Abstract][Full Text] [Related]
18. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
[TBL] [Abstract][Full Text] [Related]
19. Modelling COVID-19 vaccine breakthrough infections in highly vaccinated Israel-The effects of waning immunity and third vaccination dose.
Feng A; Obolski U; Stone L; He D
PLOS Glob Public Health; 2022; 2(11):e0001211. PubMed ID: 36962648
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 booster vaccine willingness.
Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
Dan Med J; 2021 Dec; 69(1):. PubMed ID: 34913428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
